360° Coverage : Glaxo Effort To Verify Gene Data Represents Step For Open Science

2 Updates

Glaxo Effort To Verify Gene Data Represents Step For Open Science

Mar 27 2014, 6:11am CDT | by

GlaxoSmithKline’s efforts to fund a 50-person effort with two top universities to verify that the proteins it is picking as targets for drugs are actually involved in the diseases the company hopes...

Filed under: news

 
 
 

26 weeks ago

Glaxo Effort To Verify Gene Data Represents Step For Open Science

Mar 27 2014, 6:11am CDT | by

GlaxoSmithKline’s efforts to fund a 50-person effort with two top universities to verify that the proteins it is picking as targets for drugs are actually involved in the diseases the company hopes to treat are a big example of the Big Pharma dropping its veil of research secrecy.

The new Centre for Therapeutic Target Validation is a collaboration between the London-based drug giant, the Wellcome Trust Sanger Institute, which is one of the top genetics research hotspots in the world, and the European Bioinformatics Institute. The effort will take a “Big Data” approach to pooling genetic data and other information to pick drug targets.

“[Glaxo are] providing people and expertise based analysts with this incredible wealth of expertise,” says Ewan Birney, who will be the interim head of the center. “They’ve been doing this for a long time and the’ve had successes and they’ve had failures and, in some sense, they’ll be bringing those into the public domain. I’ve been surprised at how engaged GSK has been scientifically and how interesting this problem is to handle.”

Almost all medicines work by blocking or otherwise affecting specific proteins. For instance, statin drugs like Lipitor block an enzyme in the liver that helps the body create cholesterol; aspirin blocks enzymes involved in causing inflammation and clotting blood.

But one big problem for drug researchers is that they often aren’t sure they understand what the proteins they are targeting with experimental medicines do. Problems in the quality of public research, which can be wrong, can make this worse. This project hopes that big data — looking at information and especially human genetics — can make the odds of success for new medicines better.

Patrick Vallance, who heads basic research at GSK, says that in the past ten years genetics has gone from being “quite misleading” to “high throughput” and “reliable.”

“Every week there are something like three new rare genetic mutations causing a very rare disease are being identified,” says Vallance. “Every week there is new data coming up on common disease genetic variations. What that does is it creates massive information that is truly about human biology. All of a sudden you get a window into things that are genuinely causal across a range of diseases.”

Of course, fifteen years ago drug company research executives, including those at Glaxo, made similar claims about the sequencing of the human genome and the data produced by a slew of hot gene data companies. That led to a great many failures, some of which took years to read out. For Glaxo, the reminders of its deals with Human Genome Sciences are recent: the lupus drug Benlysta, which worked but has not generated much in the way of sales, and darapladib, a much hyped heart drug that recently failed in a big trial and that also, it turned out, had the unfortunate side effect of making patients smell bad.

But Vallance provides a strong argument that things are different this time. Creating drugs has always been about finding the right proteins to target, he says. Now genetics has become the best way to do that.

Birney insists that genetics provides something that other methods of biology don’t. When you look at a person’s genes, they’ll be for the most part the same throughout life. So when a gene is linked to a disease, it gives a real clue as to how the biology of a disease works. That’s how rare mutations that cause super-high cholesterol led to the cholesterol-lowering statins, and that’s how Birney and Vallance hope that this effort will lead to new drugs.

It used to be that drug companies tried to keep much of their biology research in-house and secret, so that they would start synthesizing promising new compounds before competitors. But this effort puts a lot more of Glaxo’s research out in the open. The bet is that the advantages of having lots of minds working on the problems of drug discovery will outweigh any advantages that secrecy would have provided.

Source: Forbes Business

 
Update
2

4 weeks ago

Khazanah throws MAS RM6b lifeline

Aug 29 2014 5:01pm CDT | Source: Business Times Singapore

August 30, 2014 1:15 AMKHAZANAH Nasional will inject RM6 billion (SS$2.4 billion) over three years to resuscitate loss-making Malaysia Airlines (MAS) under a recovery plan that includes even an Act of Parliament. Other key moves are migrating its operations, assets and liabilities to a new company (NewCo) and slashing the workforc ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 
Update
1

4 weeks ago

MAS posts loss of RM307m for Q2

Aug 28 2014 5:00pm CDT | Source: Business Times Singapore

August 29, 2014 1:13 AMMALAYSIA Airlines (MAS) registered a loss of RM307 million (S$122 million) for the second quarter to end-June, but warned of worse to come in the second half when the "full financial impact of the double trage ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

Sought access for Indian companies to American markets: Modi
Washington, Sep 30 (IANS) Prime Minister Narendra Modi said Tuesday that he has urged US President Barack Obama to take steps that would help Indian service companies get access to the US economy.
 
 
Unique 'signature' found in ageing brain
London, Sep 30 (IANS) In a discovery that may lead to treatments that can slow or reverse cognitive decline in the elderly, researchers have found evidence of a unique "signature" in the ageing brain.
 
 
Why drinking makes a smile more contagious among men
New York, Sep 30 (IANS) Alcohol induces a sort of "social bravery" among men, disrupting processes that would normally prevent them from responding to another person's smile, says an interesting study.
 
 
Sleep twitches connected to brain development in babies
Sleep twitches activate circuits throughout the developing brain, says the study, suggesting that twitches teach newborns about their limbs and what they can do with them.
 
 
 

Latest from the Network

Hong Kong students threaten to occupy government offices
Hong Kong, Sep 30 (IANS/EFE) Student demonstrators have decided to step up their street protests and are planning to eventually take over and occupy government offices, leaders of the Hong Kong Federation of Students...
Read more on Politics Balla
 
US slaps sanctions on Pakistan-based terror groups
Washington, Sep 30 (IANS) The US Tuesday targeted two terrorist groups based in Pakistan by slapping sanctions on their leader and financial supporters. The Department of Treasury branded Fazl-ur Rehman Khalil, the...
Read more on Politics Balla
 
Elton John performed at Neil Patrick Harris' wedding
Neil Patrick Harris has revealed Sir Elton John gave a surprise performance at his wedding. The 'Gone Girl' star tied the knot with his long-term partner David Burtka at a castle near Perugia in Italy on September 6 and...
Read more on Celebrity Balla
 
Molly Sims pregnant again
Molly Sims is pregnant with her second child. The model-and-actress has announced she is expecting another baby with her husband, film producer Scott Stuber, and she can't wait for their two-year-old son Brooks to...
Read more on Celebrity Balla
 
Sadie Frost says Kate Moss oozes 'sex'
Sadie Frost thinks Kate Moss ''radiates sex''. The 49-year-old actress-and-producer has been friends with the supermodel for decades and says her aura has an permanently erotic element to it. Speaking to the new issue...
Read more on Celebrity Balla
 
Hamas wants Islamic state on all Palestinian lands: Official
Gaza, Sep 30 (IANS) A senior Hamas official announced Tuesday that his movement still believes in establishing an Islamic state on all the lands of Palestine. Mahmoud al-Zahar, the Hamas strongman, said in a ceremony...
Read more on Politics Balla
 
Asian Games: Indian men and women in semifinals
Incheon, Sep 30 (IANS) The Indian men and women's kabaddi teams made it to the semifinals of the 17th Asian Games after topping their respective groups here Tuesday. The men's team, record six time champions, brushed...
Read more on Sport Balla
 
Israeli settlers seize houses in east Jerusalem
Jerusalem, Sep 30 (IANS) Dozens of Jewish settlers, escorted by heavy police force, took over at least seven empty buildings in the Palestinian neighbourhood of Silwan in east Jerusalem Tuesday. The buildings are...
Read more on Politics Balla
 
Indian men paddlers in Asiad pre-quarters
Incheon, Sep 30 (IANS) Indian men paddlers advanced to the doubles pre-quarterfinals after winning their respective matches of the 17th Asian Games at the Suwon Gymnasium here Tuesday. First up, the pair of Achanta...
Read more on Sport Balla
 
IS releases third video of British hostage
Beirut, Sep 30 (IANS/EFE) The Islamic State (IS) Sunni radical organisation has published a third video of British journalist and hostage John Cantlie in which he criticizes US President President Barack Obama's...
Read more on Politics Balla